Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 1.780
-0.090 (-4.81%)
Feb 11, 2026, 2:44 PM CET
14.54% (1Y)
| Market Cap | 197.31M +67.0% |
| Revenue (ttm) | 50.03M -18.6% |
| Net Income | -25.65M |
| EPS | -0.31 |
| Shares Out | 105.52M |
| PE Ratio | n/a |
| Forward PE | 18.70 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,201,067 |
| Average Volume | 424,065 |
| Open | 1.895 |
| Previous Close | 1.870 |
| Day's Range | 1.705 - 1.900 |
| 52-Week Range | 0.360 - 1.885 |
| Beta | -0.72 |
| RSI | 75.59 |
| Earnings Date | Feb 12, 2026 |